232 related articles for article (PubMed ID: 31525070)
1. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction.
Leite S; Cerqueira RJ; Ibarrola J; Fontoura D; Fernández-Celis A; Zannad F; Falcão-Pires I; Paulus WJ; Leite-Moreira AF; Rossignol P; López-Andrés N; Lourenço AP
Circ Heart Fail; 2019 Jul; 12(7):e005596. PubMed ID: 31525070
[TBL] [Abstract][Full Text] [Related]
2. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
[TBL] [Abstract][Full Text] [Related]
3. Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.
Leite S; Rodrigues S; Tavares-Silva M; Oliveira-Pinto J; Alaa M; Abdellatif M; Fontoura D; Falcão-Pires I; Gillebert TC; Leite-Moreira AF; Lourenço AP
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1648-54. PubMed ID: 26408538
[TBL] [Abstract][Full Text] [Related]
4. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
5. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
[TBL] [Abstract][Full Text] [Related]
7. Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction.
Leite S; Moreira-Costa L; Cerqueira R; Sousa-Mendes C; Angélico-Gonçalves A; Fontoura D; Vasques-Nóvoa F; Leite-Moreira AF; Lourenço AP
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):690-701. PubMed ID: 34328815
[TBL] [Abstract][Full Text] [Related]
8. Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
Leite S; Oliveira-Pinto J; Tavares-Silva M; Abdellatif M; Fontoura D; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1556-63. PubMed ID: 25862827
[TBL] [Abstract][Full Text] [Related]
9. Spectral transfer function analysis of respiratory hemodynamic fluctuations predicts end-diastolic stiffness in preserved ejection fraction heart failure.
Abdellatif M; Leite S; Alaa M; Oliveira-Pinto J; Tavares-Silva M; Fontoura D; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H4-13. PubMed ID: 26475584
[TBL] [Abstract][Full Text] [Related]
10. The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
Stolina M; Luo X; Dwyer D; Han CY; Chen R; Zhang Y; Xiong Y; Chen Y; Yin J; Shkumatov A; Ason B; Hale C; Véniant MM
PLoS One; 2020; 15(8):e0231234. PubMed ID: 32804947
[TBL] [Abstract][Full Text] [Related]
11. Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
Park SH; Farooq MA; Gaertner S; Bruckert C; Qureshi AW; Lee HH; Benrahla D; Pollet B; Stephan D; Ohlmann P; Lessinger JM; Mayoux E; Auger C; Morel O; Schini-Kerth VB
Cardiovasc Diabetol; 2020 Feb; 19(1):19. PubMed ID: 32070346
[TBL] [Abstract][Full Text] [Related]
12. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
[TBL] [Abstract][Full Text] [Related]
13. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
[TBL] [Abstract][Full Text] [Related]
14. Histological and haemodynamic characterization of right ventricle in sedentary and trained rats with heart failure with preserved ejection fraction.
Oliveira MI; Leite S; Barros A; Lourenço AP; Mendes C; Schmidt C; Santos M; Leite-Moreira A; Moreira-Gonçalves D
Exp Physiol; 2021 Dec; 106(12):2457-2471. PubMed ID: 34676608
[TBL] [Abstract][Full Text] [Related]
15. Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction.
Desai AS; Mitchell GF; Fang JC; Creager MA
J Card Fail; 2009 Oct; 15(8):658-64. PubMed ID: 19786254
[TBL] [Abstract][Full Text] [Related]
16. Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction.
Büttner P; Adams V; Werner S; Ossmann S; Besler C; Schwedhelm E; Thiele H
ESC Heart Fail; 2022 Dec; 9(6):4348-4351. PubMed ID: 36043453
[TBL] [Abstract][Full Text] [Related]
17. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction.
Schauer A; Draskowski R; Jannasch A; Kirchhoff V; Goto K; Männel A; Barthel P; Augstein A; Winzer E; Tugtekin M; Labeit S; Linke A; Adams V
ESC Heart Fail; 2020 Oct; 7(5):2123-2134. PubMed ID: 32710530
[TBL] [Abstract][Full Text] [Related]
18. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF.
Summer G; Kuhn AR; Munts C; Miranda-Silva D; Leite-Moreira AF; Lourenço AP; Heymans S; Falcão-Pires I; van Bilsen M
J Mol Cell Cardiol; 2020 Jul; 144():66-75. PubMed ID: 32422321
[TBL] [Abstract][Full Text] [Related]
19. Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction.
Büttner P; Werner S; Baskal S; Tsikas D; Adams V; Lurz P; Besler C; Knauth S; Bahls M; Schwedhelm E; Thiele H
Sci Rep; 2021 Oct; 11(1):20684. PubMed ID: 34667218
[TBL] [Abstract][Full Text] [Related]
20. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA
J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
